+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cell Biomanufacturing Market - Global Forecast 2026-2032- Product Image
Stem Cell Biomanufacturing Market - Global Forecast 2026-2032- Product Image
Sale

Stem Cell Biomanufacturing Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134844
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Stem Cell Biomanufacturing Market is projected to reach USD 3.05 Billion in 2026. It is expected to continue growing at a CAGR of 10.72%, reaching USD 5.60 Billion by 2032.

Stem Cell Biomanufacturing: Executive Overview

Stem cell biomanufacturing covers the controlled development, production, characterization, and quality assurance of stem-cell-based materials and therapies. The field connects cell biology with process engineering, automation, analytics, cryopreservation, and regulatory science. Its strategic importance is rising as developers seek reproducible cell sources, consistent product quality, scalable workflows, and clinically suitable manufacturing systems.

From Bespoke Cell Workflows to Standardized Production Platforms

The landscape is shifting from laboratory-specific procedures toward standardized, closed, and increasingly automated production platforms. Key priorities include defined media, xeno-free inputs, robust cell banks, process comparability, real-time monitoring, and stronger control of identity, potency, purity, and genetic stability. Manufacturing teams are also placing greater emphasis on modular facilities, single-use technologies, digital batch records, and supply-chain resilience to reduce variability between development and clinical production.

Artificial Intelligence Strengthens Process Control and Decision-Making

Artificial intelligence is contributing to stem cell biomanufacturing through image analysis, culture-condition optimization, anomaly detection, predictive maintenance, and integration of high-dimensional quality data. Machine-learning tools can help identify relationships between process parameters and cell attributes, while computer vision supports more consistent assessment of morphology and confluence. Adoption remains dependent on validated data pipelines, representative training datasets, explainable models, cybersecurity, and regulatory acceptance of algorithm-assisted manufacturing decisions.

Regional Insights: Capability Is Expanding Through Different Manufacturing Models

North America combines advanced translational infrastructure, specialized manufacturing expertise, and established regulatory pathways, while Europe emphasizes quality systems, cross-border standards, and public-private research networks. Asia-Pacific is strengthening its position through substantial research capacity, expanding clinical activity, and investments in advanced bioprocessing. Latin America is developing capabilities through academic, hospital, and technology-transfer networks, although access to specialized infrastructure varies. The Middle East is using healthcare modernization and life-science investment to build selected advanced-therapy capabilities, while Africa’s progress is centered on research institutions, clinical partnerships, workforce development, and fit-for-purpose manufacturing access.

Group Insights: Policy Alignment and Industrial Capacity Shape Progress

ASEAN countries are pursuing regional collaboration while addressing differences in regulation, infrastructure, and technical workforce depth. BRICS members span mature, rapidly developing, and emerging biomanufacturing ecosystems, creating opportunities for knowledge exchange alongside uneven access to specialized inputs. The European Union benefits from coordinated scientific and regulatory structures, whereas the G7 brings deep capabilities in research, manufacturing engineering, and clinical translation. GCC countries are investing in healthcare diversification and biotechnology infrastructure, while NATO members benefit from extensive scientific networks and resilient technology ecosystems, though national regulatory and reimbursement conditions remain distinct.

Country Insights: Diverse Strengths Across Research, Regulation, and Manufacturing

Australia combines strong biomedical research with growing translational capacity. Brazil and Mexico are expanding regional capabilities through academic and healthcare networks. Canada and the United States have broad research, clinical, and advanced-manufacturing ecosystems. China, Japan, and South Korea are advancing cell-processing infrastructure, automation, and regenerative-medicine development. India is strengthening its biopharmaceutical and clinical-manufacturing base. France, Germany, Italy, Spain, and the United Kingdom contribute established research institutions, specialized engineering, and structured regulatory experience. Russia retains scientific capabilities but faces constraints related to international access, supply chains, and collaboration. Across these countries, progress depends on validated processes, skilled personnel, dependable raw materials, and alignment between developers, regulators, clinicians, and payers.

Actions for Leaders: Build Quality, Flexibility, and Evidence Into the Operating Model

Industry leaders should prioritize platform processes that can be adapted across cell types without weakening comparability or quality control. Investments should focus on closed processing, automation, robust cell banks, analytical methods, and digital traceability, supported by early regulatory engagement. Organizations should establish governance for artificial intelligence, including data standards, model validation, human oversight, and change control. Partnerships with hospitals, academic centers, technology providers, and specialized suppliers can accelerate translation, while workforce programs and dual-source procurement can reduce operational vulnerability.

Research Methodology: Evidence-Based Synthesis of Manufacturing Drivers

This executive summary uses the defined scope of stem cell biomanufacturing and organizes evidence around production technologies, quality systems, automation, artificial intelligence, regulation, infrastructure, and regional ecosystem conditions. The analysis compares the required regions, country groups, and countries qualitatively, focusing on documented capabilities, policy direction, research activity, clinical translation, and operational constraints. It intentionally excludes market estimates, market shares, forecasts, and company-specific assessments, and treats differences in regulatory maturity and infrastructure as material factors in interpretation.

Conclusion: Scalable, Reproducible Manufacturing Will Determine Translation

Stem cell biomanufacturing is moving toward more controlled, data-rich, and scalable production systems. The strongest progress will come from combining biological understanding with engineering discipline, validated analytics, automation, and responsible use of artificial intelligence. Regional and national ecosystems will advance at different speeds, but durable leadership will depend on reproducibility, regulatory readiness, supply resilience, and evidence that manufacturing performance translates into consistent clinical quality.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Stem Cell Biomanufacturing Market, by Product Type
7.1. Introduction
7.2. Consumables
7.2.1. Media
7.2.2. Microcarrier Beads
7.3. Equipment
7.3.1. Bioreactors
7.3.2. Cell Counters
7.4. Raw Material
7.4.1. Cytokines
7.4.2. Growth Factors
8. Stem Cell Biomanufacturing Market, by Cell Type
8.1. Introduction
8.2. Adult
8.2.1. Hematopoietic
8.2.2. Mesenchymal
8.3. Embryonic
8.4. Induced Pluripotent
8.4.1. 3D Culture
8.4.2. Monolayer Culture
9. Stem Cell Biomanufacturing Market, by Bioprocessing Technology
9.1. Introduction
9.2. Bioreactor
9.3. Microcarrier
9.3.1. Cultispher Series
9.3.2. Cytodex Series
9.4. Stirred Tank
10. Stem Cell Biomanufacturing Market, by Service
10.1. Introduction
10.2. Analytical
10.2.1. Flow Cytometry
10.2.2. Quality Testing
10.3. Process Development
10.3.1. Downstream
10.3.2. Upstream
11. Stem Cell Biomanufacturing Market, by Application
11.1. Introduction
11.2. Disease Modeling
11.2.1. Cardiovascular
11.2.2. Neurodegenerative
11.3. Drug Discovery
11.4. Regenerative Therapy
11.4.1. Cell Therapy
11.4.2. Tissue Engineering
12. Stem Cell Biomanufacturing Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Stem Cell Biomanufacturing Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Stem Cell Biomanufacturing Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Athersys, Inc.
16.2. Bio-Rad Laboratories, Inc.
16.3. BlueRock Therapeutics LP
16.4. Celularity Inc.
16.5. Century Therapeutics, Inc.
16.6. CRISPR Therapeutics AG
16.7. Fate Therapeutics, Inc.
16.8. FUJIFILM Holdings Corporation
16.9. Lineage Cell Therapeutics, Inc.
16.10. Lonza Group AG
16.11. Merck KGaA
16.12. Miltenyi Biotec GmbH
16.13. Orchard Therapeutics plc
16.14. Promocell GmbH
16.15. Sana Biotechnology, Inc.
16.16. STEMCELL Technologies Inc.
16.17. Takara Bio Inc.
16.18. Thermo Fisher Scientific Inc.
16.19. Vericel Corporation
16.20. Vertex Pharmaceuticals Incorporated
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Stem Cell Biomanufacturing Market, Years Considered for the Study
FIGURE 2. Global Stem Cell Biomanufacturing Market, Research Design
FIGURE 3. Global Stem Cell Biomanufacturing Market, Research Framework
FIGURE 4. Global Stem Cell Biomanufacturing Market, Data Triangulation
FIGURE 5. Global Stem Cell Biomanufacturing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Stem Cell Biomanufacturing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Stem Cell Biomanufacturing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Stem Cell Biomanufacturing Market Size, by Cell Type, 2025 vs 2032 (%)
FIGURE 9. Global Stem Cell Biomanufacturing Market Size, by Cell Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2025 vs 2032 (%)
FIGURE 11. Global Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Stem Cell Biomanufacturing Market Size, by Service, 2025 vs 2032 (%)
FIGURE 13. Global Stem Cell Biomanufacturing Market Size, by Service, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Stem Cell Biomanufacturing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Stem Cell Biomanufacturing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Stem Cell Biomanufacturing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Stem Cell Biomanufacturing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Stem Cell Biomanufacturing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Stem Cell Biomanufacturing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Stem Cell Biomanufacturing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Stem Cell Biomanufacturing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Stem Cell Biomanufacturing Market Segmentation & Coverage
TABLE 2. Global Stem Cell Biomanufacturing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Microcarrier Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Microcarrier Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Microcarrier Beads Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Bioreactors Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Bioreactors Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Bioreactors Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Cell Counters Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Cell Counters Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Cell Counters Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Raw Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Raw Material Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Raw Material Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cytokines Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cytokines Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cytokines Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Growth Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Growth Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Growth Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 32. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Hematopoietic Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Hematopoietic Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Hematopoietic Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Mesenchymal Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Mesenchymal Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Mesenchymal Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Embryonic Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Embryonic Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Embryonic Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Induced Pluripotent Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Induced Pluripotent Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Induced Pluripotent Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global 3D Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global 3D Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global 3D Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Monolayer Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Monolayer Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Monolayer Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 54. Global Bioreactor Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Bioreactor Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Bioreactor Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Microcarrier Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Microcarrier Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Microcarrier Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Cultispher Series Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Cultispher Series Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Cultispher Series Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Cytodex Series Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Cytodex Series Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Cytodex Series Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Stirred Tank Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Stirred Tank Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Stirred Tank Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 70. Global Analytical Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Analytical Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Analytical Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Quality Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Quality Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Quality Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Process Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Process Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Process Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Downstream Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Downstream Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Downstream Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Upstream Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Upstream Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Upstream Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Global Disease Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Disease Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Disease Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Neurodegenerative Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Neurodegenerative Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Neurodegenerative Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Regenerative Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Regenerative Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Regenerative Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Tissue Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Tissue Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Tissue Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 127. North America Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. North America Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. North America Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 130. North America Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 131. North America Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 132. North America Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 133. North America Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 134. North America Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 135. North America Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 136. North America Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 137. North America Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 138. North America Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 139. North America Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 140. North America Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. North America Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 142. North America Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 143. Latin America Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Latin America Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. Latin America Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 146. Latin America Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 147. Latin America Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 148. Latin America Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 149. Latin America Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 150. Latin America Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 151. Latin America Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 152. Latin America Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 153. Latin America Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 154. Latin America Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 155. Latin America Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 156. Latin America Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Latin America Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 158. Latin America Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 159. Europe Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Europe Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. Europe Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 162. Europe Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 163. Europe Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 164. Europe Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 165. Europe Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 166. Europe Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 167. Europe Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 168. Europe Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 169. Europe Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 170. Europe Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 171. Europe Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 172. Europe Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Europe Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 174. Europe Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 175. Middle East Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Middle East Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Middle East Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 178. Middle East Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 179. Middle East Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 180. Middle East Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 181. Middle East Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 182. Middle East Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 183. Middle East Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 184. Middle East Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 185. Middle East Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 186. Middle East Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 187. Middle East Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 188. Middle East Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Middle East Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 190. Middle East Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 191. Africa Stem Cell Biomanufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. Africa Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. Africa Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 194. Africa Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 195. Africa Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 196. Africa Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 197. Africa Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 198. Africa Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 199. Africa Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 200. Africa Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 201. Africa Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 202. Africa Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 203. Africa Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 204. Africa Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Africa Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 206. Africa Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 207. Global Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. ASEAN Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. ASEAN Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. ASEAN Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 211. ASEAN Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 212. ASEAN Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 213. ASEAN Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 214. ASEAN Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 215. ASEAN Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 216. ASEAN Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 217. ASEAN Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 218. ASEAN Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 219. ASEAN Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 220. ASEAN Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 221. ASEAN Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. ASEAN Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 223. ASEAN Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 224. GCC Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. GCC Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. GCC Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 227. GCC Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 228. GCC Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 229. GCC Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 230. GCC Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 231. GCC Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 232. GCC Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 233. GCC Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 234. GCC Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 235. GCC Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 236. GCC Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 237. GCC Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. GCC Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 239. GCC Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 240. European Union Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. European Union Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. European Union Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 243. European Union Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 244. European Union Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 245. European Union Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 246. European Union Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 247. European Union Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 248. European Union Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 249. European Union Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 250. European Union Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 251. European Union Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 252. European Union Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 253. European Union Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. European Union Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 255. European Union Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 256. BRICS Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. BRICS Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. BRICS Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 259. BRICS Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 260. BRICS Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 261. BRICS Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 262. BRICS Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 263. BRICS Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 264. BRICS Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 265. BRICS Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 266. BRICS Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 267. BRICS Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 268. BRICS Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 269. BRICS Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. BRICS Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 271. BRICS Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 272. G7 Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 273. G7 Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. G7 Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 275. G7 Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 276. G7 Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 277. G7 Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 278. G7 Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 279. G7 Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 280. G7 Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 281. G7 Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 282. G7 Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 283. G7 Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 284. G7 Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 285. G7 Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. G7 Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 287. G7 Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 288. NATO Stem Cell Biomanufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. NATO Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. NATO Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 291. NATO Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 292. NATO Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 293. NATO Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 294. NATO Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 295. NATO Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 296. NATO Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 297. NATO Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 298. NATO Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 299. NATO Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 300. NATO Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 301. NATO Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. NATO Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 303. NATO Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 304. Global Stem Cell Biomanufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 305. United States Stem Cell Biomanufacturing Market Size, 2017-2032 (USD Million)
TABLE 306. United States Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 307. United States Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 308. United States Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 309. United States Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 310. United States Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 311. United States Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 312. United States Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 313. United States Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 314. United States Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 315. United States Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 316. United States Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 317. United States Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 318. United States Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. United States Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 320. United States Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 321. Canada Stem Cell Biomanufacturing Market Size, 2017-2032 (USD Million)
TABLE 322. Canada Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 323. Canada Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 324. Canada Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 325. Canada Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 326. Canada Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 327. Canada Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 328. Canada Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 329. Canada Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 330. Canada Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 331. Canada Stem Cell Biomanufacturing Market Size, by Service, 2017-2032 (USD Million)
TABLE 332. Canada Stem Cell Biomanufacturing Market Size, by Analytical, 2017-2032 (USD Million)
TABLE 333. Canada Stem Cell Biomanufacturing Market Size, by Process Development, 2017-2032 (USD Million)
TABLE 334. Canada Stem Cell Biomanufacturing Market Size, by Application, 2017-2032 (USD Million)
TABLE 335. Canada Stem Cell Biomanufacturing Market Size, by Disease Modeling, 2017-2032 (USD Million)
TABLE 336. Canada Stem Cell Biomanufacturing Market Size, by Regenerative Therapy, 2017-2032 (USD Million)
TABLE 337. Mexico Stem Cell Biomanufacturing Market Size, 2017-2032 (USD Million)
TABLE 338. Mexico Stem Cell Biomanufacturing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. Mexico Stem Cell Biomanufacturing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 340. Mexico Stem Cell Biomanufacturing Market Size, by Equipment, 2017-2032 (USD Million)
TABLE 341. Mexico Stem Cell Biomanufacturing Market Size, by Raw Material, 2017-2032 (USD Million)
TABLE 342. Mexico Stem Cell Biomanufacturing Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 343. Mexico Stem Cell Biomanufacturing Market Size, by Adult, 2017-2032 (USD Million)
TABLE 344. Mexico Stem Cell Biomanufacturing Market Size, by Induced Pluripotent, 2017-2032 (USD Million)
TABLE 345. Mexico Stem Cell Biomanufacturing Market Size, by Bioprocessing Technology, 2017-2032 (USD Million)
TABLE 346. Mexico Stem Cell Biomanufacturing Market Size, by Microcarrier, 2017-2032 (USD Million)
TABLE 347. Mexico Stem Cell Biomanufacturing Market Size, by

Companies Mentioned

  • Athersys, Inc.
  • Bio-Rad Laboratories, Inc.
  • BlueRock Therapeutics LP
  • Celularity Inc.
  • Century Therapeutics, Inc.
  • CRISPR Therapeutics AG
  • Fate Therapeutics, Inc.
  • FUJIFILM Holdings Corporation
  • Lineage Cell Therapeutics, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Orchard Therapeutics plc
  • Promocell GmbH
  • Sana Biotechnology, Inc.
  • STEMCELL Technologies Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Vericel Corporation
  • Vertex Pharmaceuticals Incorporated

Related Topics

Related Reports

Stem Cell Assays Market - Global Forecast 2026-2032 - Product Image

Stem Cell Assays Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Human Embryonic Stem Cells Market - Global Forecast 2026-2032 - Product Image

Human Embryonic Stem Cells Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Cell Reprogramming Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Cell Reprogramming Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Stem Cell Services - Global Strategic Business Report - Product Image

Stem Cell Services - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Induced Pluripotent Stem Cells Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Induced Pluripotent Stem Cells Production Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 177 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.